Healthcare Cognitive Computing Market Report 2026

The healthcare cognitive computing market size has grown exponentially in recent years. It will grow from $8.92 billion in 2025 to $11.19 billion in 2026 at a compound annual growth rate (CAGR) of 25.4%. The growth in the historic period can be attributed to increasing volume of unstructured healthcare data, growth in electronic health record adoption, rising need for clinical decision support, expansion of medical research datasets, availability of advanced analytics platforms.

The healthcare cognitive computing market size is expected to see exponential growth in the next few years. It will grow to $27.22 billion in 2030 at a compound annual growth rate (CAGR) of 24.9%. The growth in the forecast period can be attributed to increasing use of AI-driven clinical insights, rising demand for precision medicine analytics, expansion of cloud-based cognitive platforms, growing adoption of predictive healthcare models, increasing focus on data-driven patient outcomes. Major trends in the forecast period include expanding use of nlp for clinical data analysis, rising adoption of cognitive decision support systems, growing integration of machine learning in diagnostics, expansion of predictive analytics in healthcare, enhanced focus on unstructured data interpretation.

The rising prevalence of chronic diseases is expected to drive growth in the healthcare cognitive computing market. Chronic, or non-communicable, diseases (NCDs) are long-lasting conditions influenced by genetic, physiological, environmental, and behavioral factors. Cognitive computing helps researchers uncover relationships among genes, proteins, pathways, phenotypes, and diseases, while generating concise summaries that highlight key aspects of a patient’s condition for both patients and healthcare providers. For example, in May 2024, UK-based patient and research charity Diabetes UK reported that approximately 4.4 million people in the UK were living with a diabetes diagnosis in 2022-23, with around 8% having type 1 diabetes and 90% having type 2. This growing prevalence of chronic diseases is fueling the healthcare cognitive computing market.

Key companies in the healthcare cognitive computing sector are focusing on generative AI-based microservices to accelerate drug discovery, medical imaging, clinical workflows, and digital-health applications across cloud and on-premises environments. These microservices are modular, GPU-accelerated building blocks, including optimized models and inference services, that can be integrated into applications for tasks such as molecule generation, protein structure prediction, imaging segmentation, transcription, and clinical-grade summarization. For instance, in March 2024, US-based accelerated computing company NVIDIA launched a catalog of over two dozen NVIDIA NIM and CUDA-X microservices for biology, chemistry, imaging, and healthcare data on NVIDIA DGX Cloud and major public clouds. The suite includes microservices for generative chemistry (MolMIM), protein folding (ESMFold), molecular docking (DiffDock), 3D imaging (VISTA 3D), and a Universal DeepVariant service that accelerates genomic variant calling. These services, available via NVIDIA AI Enterprise 5 and NVIDIA-certified systems, are being adopted by biopharma and medtech partners to embed AI into drug discovery, imaging, and clinical workflows.

In July 2025, Sweden-based private equity firm Nordic Capital acquired US-based healthcare cognitive computing provider Arcadia Solutions for an undisclosed amount. This acquisition aims to strengthen Nordic Capital’s investment in AI-powered healthcare delivery and analytics by leveraging Arcadia’s data infrastructure and provider/payer client base.

Major companies operating in the healthcare cognitive computing market are Apixio Inc.; CognitiveScale; Healthcare X.0 GmbH; MedWhat; Palantir Technologies Inc.; Google LLC; Microsoft Corporation; International Business Machines Corporation; Enterra Solutions; Saffron Technology Inc.; DeepMind Technologies Limited; Nuance Communications Incorporated; Ayasdi Inc.; Health Fidelity Inc.; Linguamatics Inc.; Suki Inc.; Welltok Inc.; Zephyr Health Inc.; Zebra Medical Vision Ltd.; Ada Health; Tempus AI Inc.; K Health; CitiusTech; Atomwise Inc.; Behold.AI Technologies Limited.

North America was the largest region in the healthcare cognitive computing market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare cognitive computing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the healthcare cognitive computing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the healthcare cognitive computing market by increasing costs of imported high-performance servers, AI accelerators, storage systems, and networking equipment required for advanced analytics workloads. Hospitals, research institutions, and pharmaceutical companies in North America and Europe are most affected due to reliance on imported computing infrastructure, while Asia-Pacific faces higher costs for system scaling. These tariffs are raising deployment and operational expenses. However, they are also encouraging greater adoption of cloud-based cognitive platforms, software optimization, and regional investments in healthcare data infrastructure that support long-term analytics growth.

The healthcare cognitive computing market research report is one of a series of new reports that provides healthcare cognitive computing market statistics, including healthcare cognitive computing industry global market size, regional shares, competitors with a healthcare cognitive computing market share, detailed healthcare cognitive computing market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare cognitive computing industry. This healthcare cognitive computing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Healthcare cognitive computing involves leveraging logic, language processing, machine learning, and human-like abilities to tackle problems and analyze vast volumes of unstructured healthcare data. Its application in the healthcare sector is crucial for handling extensive datasets encompassing patient histories, diagnoses, illnesses, and scholarly research papers.

The key technologies within healthcare cognitive computing comprise natural language processing (NLP), machine learning, automated reasoning, and other related advancements. NLP specifically empowers machines to comprehend, interpret, and extract meaning from human languages. These technologies can be deployed through on-premises systems or cloud-based platforms, catering to a range of end-users including hospitals, pharmaceutical companies, medical device manufacturers, insurance providers, and various other stakeholders within the healthcare industry.

The healthcare cognitive computing market consists of revenues earned by entities by providing cognitive computing solutions to accomplish tasks that require the parsing of large amounts of data to extract and use the information to enhance decision-making capabilities in the healthcare sector such as clinical research, maintaining electronic health records, personalized care, and medical image processing. The market value includes the value of related goods sold by the service provider or included within the service offering. The healthcare cognitive computing market also includes the sales of cognitive computing systems that analyze and provide healthcare insights. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.